Suchergebnisse - "Eşkazan, Ahmet Emre"

PubPharm (238)

31

Editorial : Advances in the treatment of chronic myeloid leukemia

enthalten in: Frontiers in oncology | 2023

von Eşkazan, A. | Kok, C. | Yeung, D. | +2

32

Guidelines for the treatment of chronic myeloid leukemia from the NCCN and ELN : differences and similarities

enthalten in: International journal of hematology | 2023

von Narlı Özdemir, Z. | Kılıçaslan, N. | Yılmaz, M. | +1

33

Diagnosis and Management of Classical Hodgkin Lymphoma During the COVID-19 Pandemic

enthalten in: Current problems in cancer | 2022

von Küçükyurt, S. | Şahin, K. | Yılmaz, U. | +9

34

Biosimilar Rituximab (Redditux) Added to CHOP Chemotherapy for De Novo Diffuse Large B-Cell Lymphoma Patients : Real-Life Single-Center Experience

enthalten in: Turkish journal of haematology : official journal of Turkish Society of Haematology | 2022

von Özbalak, M. | Güzel Mastanzade, M. | Özlük, �. | +14

35

Successful Management of Ibrutinib-Induced Thrombocytopenia with Eltrombopag in a Patient with Waldenström Macroglobulinemia

enthalten in: Turkish journal of haematology : official journal of Turkish Society of Haematology | 2022

von Erçalışkan, A. | Avcı, F. | Eşkazan, A.

36

Olverembatinib in chronic myeloid leukemia

enthalten in: Drugs of today (Barcelona, Spain : 1998) | 2022

von Öziskender, R. | Eşkazan, A.

37

Kikuchi Fujimoto disease as the presenting component of VEXAS syndrome : a case report of a probable association

enthalten in: Clinical rheumatology | 2022

von Yılmaz, U. | Güner, S. | Eşkazan, T. | +5

38

Cytogenetic profile of adult AML patients in Turkey : a single center study with comprehensive comparison with literature

enthalten in: African health sciences | 2022

von Cirakoglu, A. | Kuru, R. | Yilmaz, S. | +13

39

Recent Advances in the Therapeutic Armamentarium of Acute Myeloid Leukemia : A Focus on the 63rd American Society of Hematology Annual Meeting Abstracts

enthalten in: Current pharmaceutical design | 2022

von Bayraktar, E. | Küçükyurt, S. | Eşkazan, A.

40

Guidelines for the treatment of chronic myeloid leukemia from the NCCN and ELN: differences and similarities

enthalten in: International journal of hematology | 2022

von Narlı Özdemir, Z. | Kılıçaslan, N. | Yılmaz, M. | +1